Genetic influence on bone turnover in postmenopausal twins

作者: P Garnero , N K Arden , G Griffiths , P D Delmas , T D Spector

DOI: 10.1210/JCEM.81.1.8550741

关键词: Internal medicineDeoxypyridinolineType I collagenEndocrinologyBone remodelingResorptionOsteocalcinOsteopeniaBiologyBone resorptionPeak bone mass

摘要: Postmenopausal bone mass is determined by both peak and subsequent loss. Previous studies have shown that under genetic influence mediated partly factors affecting formation. The rate of loss increases markedly after the menopause, but highly variable from subject to subject. aims this study were determine whether postmenopausal turnover was control, which should be linked on A classical twin performed compared intraclass correlations in monozygotic (MZ) twins with those dizygotic (DZ) twins, any difference assumed due factors. Markers formation resorption measured 240 untreated aged 45-69 yr, average 12.3 yr (SD, 6.0) postmenopause, including 61 MZ pairs 59 DZ pairs. correlation coefficient pairs, rMZ (95% confidence interval), for 2 specific markers formation, serum osteocalcin bone-specific alkaline phosphatase, higher than corresponding rDZ [0.67 (range, 0.59-0.75) vs. 0.48 0.35-0.61; P = 0.06) 0.53 0.41-0.65) 0.21 0.01-0.41; 0.02) phosphatase]. For propeptide type I collagen, a collagen synthesis marker exhibits only slight increase high proportion its variance explained [rMZ 0.82 (0.77-0.87), 0.33 (0.16-0.50); < 0.001]. three distinct urinary markers, total deoxypyridinoline two cross-linked peptides (CrossLaps NTX), menopause reached significance NTX (P 0.03). free dexoypyridinoline, reflecting degradation moderately significant 0.002). In conclusion, our data indicate levels are factors, contribution clearly do not change at menopause. These suggest overall possibly likely small.

参考文章(36)
C. C. Johnston, J. C. Christian, Pao-Lo Yu, C. W. Slemenda, Heritability of bone mass: a longitudinal study in aging male twins. American Journal of Human Genetics. ,vol. 44, pp. 429- 433 ,(1989)
Simon P. Robins, Henning Woitge, Robert Hesley, Julia Ju, Saeid Seyedin, Markus J. Seibel, Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption Journal of Bone and Mineral Research. ,vol. 9, pp. 1643- 1649 ,(2009) , 10.1002/JBMR.5650091019
C. Hassager, G. Fabbri-Mabelli, C. Christiansen, The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of type I collagen. Osteoporosis International. ,vol. 3, pp. 50- 52 ,(1993) , 10.1007/BF01623177
David R. Eyre, Thomas J. Koob, Kirk P. Van Ness, Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Analytical Biochemistry. ,vol. 137, pp. 380- 388 ,(1984) , 10.1016/0003-2697(84)90101-5
Saeid M. Seyedin, Viola T. Kung, Yuri N. Daniloff, Robert P. Hesley, Baltazar Gomez, Lori A. Nielsen, Harold N. Rosen, Robert F. Zuk, Immunoassay for urinary pyridinoline: The new marker of bone resorption Journal of Bone and Mineral Research. ,vol. 8, pp. 635- 641 ,(2009) , 10.1002/JBMR.5650080515
A Tokita, P J Kelly, T V Nguyen, J C Qi, N A Morrison, L Risteli, J Risteli, P N Sambrook, J A Eisman, Genetic influences on type I collagen synthesis and degradation: further evidence for genetic regulation of bone turnover. The Journal of Clinical Endocrinology and Metabolism. ,vol. 78, pp. 1461- 1466 ,(1994) , 10.1210/JCEM.78.6.8200950
F G Hustmyer, M Peacock, S Hui, C C Johnston, J Christian, Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus. Journal of Clinical Investigation. ,vol. 94, pp. 2130- 2134 ,(1994) , 10.1172/JCI117568
JULIA S. JOHANSEN, B. J. RIIS, P. D. DELMAS, C. CHRISTIANSEN, Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women European Journal of Clinical Investigation. ,vol. 18, pp. 191- 195 ,(1988) , 10.1111/J.1365-2362.1988.TB02412.X
C. Hassager, L. T. Jensen, J. P�denphant, K. Thomsen, C. Christiansen, The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy. Calcified Tissue International. ,vol. 54, pp. 30- 33 ,(1994) , 10.1007/BF00316286
P D Delmas, D Stenner, H W Wahner, K G Mann, B L Riggs, Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. Journal of Clinical Investigation. ,vol. 71, pp. 1316- 1321 ,(1983) , 10.1172/JCI110882